Application of pharmaceutical profiling assays for optimization of drug-like properties

被引：0
|
作者：
Di, L [1 ]
Kerns, EH [1 ]
机构：
[1] Wyeth Inc, Monmouth Jct, NJ 08852 USA
来源：
CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT | 2005年 / 8卷 / 04期
关键词：
ADME/toxicity; blood-brain barrier; cytochrome P450 inhibition; metabolism; solubility; stability; permeability; prodrugs;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Pharmaceutical profiling assays provide an early assessment of drug-like properties, such as solubility, permeability, metabolism, stability and drug-drug interactions. This information can be used to alert project teams to potential property issues, predict and diagnose in vivo assay results, guide structure-property relationships, provide insight into structure modification, and help drug discovery teams to make informed decisions. Successful drugs can be developed when biological activities of interest and pharmaceutical properties are optimized in parallel.
引用
收藏
页码：495 / 504
页数：10
相关论文
共 50 条
  • [1] Profiling drug-like properties in discovery research
    Di, L
    Kerns, EH
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2003, 7 (03) : 402 - 408
  • [2] Drug-Like Property Concepts in Pharmaceutical Design
    Di, Li
    Kerns, Edward H.
    Carter, Guy T.
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (19) : 2184 - 2194
  • [3] Synthesis and optimization of stapled DOCK peptides with improved drug-like properties
    Theppawong, Atiruj
    De Geyter, Ewout
    Madder, Annemieke
    ARKIVOC, 2024, : 1 - 17
  • [4] Recognizing molecules with drug-like properties
    Walters, WP
    Murcko, A
    Murcko, MA
    CURRENT OPINION IN CHEMICAL BIOLOGY, 1999, 3 (04) : 384 - 387
  • [5] Optimization of Drug-Like Properties of Nonsteroidal Glucocorticoid Mimetics and Identification of a Clinical Candidate
    Harcken, Christian
    Riether, Doris
    Liu, Pingrong
    Razavi, Hossein
    Patel, Usha
    Lee, Thomas
    Bosanac, Todd
    Ward, Yancey
    Ralph, Mark
    Chen, Zhidong
    Souza, Donald
    Nelson, Richard M.
    Kukulka, Alison
    Fadra-Khan, Tazmeen N.
    Zuvela-Jelaska, Ljiljana
    Patel, Mita
    Thomson, David S.
    Nabozny, Gerald H.
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (12): : 1318 - 1323
  • [6] The Role of Fluorine in the Discovery and Optimization of CNS Agents: Modulation of Drug-Like Properties
    Hodgetts, Kevin J.
    Combs, Kerry J.
    Elder, Amy M.
    Harriman, Geraldine C.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 45, 2010, 45 : 429 - +
  • [7] Prodrug strategies for improving drug-like properties
    Stella, Valentino J.
    OPTIMIZING THE DRUG-LIKE PROPERTIES OF LEADS IN DRUG DISCOVERY, 2006, 4 : 221 - 242
  • [8] Electronic properties and intermolecular binding in drug-like molecules
    Clark, Tim
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [9] Novel kappa opioid peptides with drug-like properties
    Aldrich, Jane V.
    Kulkarni, Santosh S.
    Senadheera, Sanjeewa N.
    Ross, Nicolette C.
    Reilley, Kate J.
    Eans, Shainnel O.
    Ganno, Michelle L.
    McLaughlin, Jay P.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [10] Drug-like index: A new approach to measure drug-like compounds and their diversity
    Xu, J
    Stevenson, J
    JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2000, 40 (05): : 1177 - 1187
12345